Immune Design Competitors and Similar CompaniesClear all

Immune Design's competitors and similar companies include ImmunoGen and Odyssey Therapeutics.
Immune Design
Immune Design
Immune Design is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body’s immune system to fight disease.
ImmunoGen
ImmunoGen
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
Odyssey Therapeutics
Odyssey Therapeutics
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
Founding Date
Founding Date
2008
Founding Date
1981
Founding Date
2021
Type
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
South San Francisco, US
Locations
Waltham, US HQ
Locations
Boston, US HQ
Frankfurt Am Main, DE
Ann Arbor, US
San Diego, US
Employees
Employees
4813% decrease
Employees
277161% increase
Employees
1481% decrease

Financial

Revenue (est.)
Revenue (est.)
$2.2m (FY, 2018)
Revenue (est.)
$108.8m (FY, 2022)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$1.4m (FY, 2018)
Cost of goods
$176k (FY, 2022)
Cost of goods
N/A
Gross profit
Gross profit
$761k (FY, 2018)
Gross profit
$108.6m (FY, 2022)
Gross profit
N/A
Net income
Net income
($54.8m) (FY, 2018)
Net income
($222.9m) (FY, 2022)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 56m
Total funding raised
$ 386m
For sources of this data, please see the company profile

View Company Profiles

ImmunoGen
HQ
Waltham, US
Employees
277

ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.

View company
Odyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease

Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.

View company